{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:01:57Z","timestamp":1790827317803,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/md.0000000000001752","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T10:39:52Z","timestamp":1446115192000},"page":"e1752","source":"Crossref","is-referenced-by-count":20,"title":["A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities"],"prefix":"10.1097","volume":"94","author":[{"given":"Yu-Jie","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chuen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiao-Lai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210226","first-page":"145","article-title":"A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses.","volume":"118","author":"Delay","year":"1960","journal-title":"Ann Med Psychol"},{"key":"R2-24-20210226","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome.","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"R3-24-20210226","first-page":"S54","article-title":"Severe and uncommon involuntary movement disorders due to psychotropic drugs.","volume":"37","author":"Stubner","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"R4-24-20210226","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1097\/CCM.0000000000000053","article-title":"Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. a case series and review of the literature.","volume":"42","author":"Saddawi-Konefka","year":"2014","journal-title":"Crit Care Med"},{"key":"R5-24-20210226","first-page":"378","article-title":"Specific treatment of the neuroleptic malignant syndrome.","volume":"44","author":"Caroff","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R6-24-20210226","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp-2014-309098","article-title":"Movement disorders in catatonia.","volume":"86","author":"Wijemanne","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R7-24-20210226","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.","volume":"15","author":"Belvederi Murri","year":"2015","journal-title":"Drugs R D"},{"key":"R8-24-20210226","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11126-013-9264-4","article-title":"Case reports of neuroleptic malignant syndrome in context of quetiapine use.","volume":"84","author":"Detweiler","year":"2013","journal-title":"Psychiatr Q"},{"key":"R9-24-20210226","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02244881","article-title":"Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report.","volume":"116","author":"Raitasuo","year":"1994","journal-title":"Psychopharmacology"},{"issue":"Suppl","key":"R10-24-20210226","first-page":"58","article-title":"Clinical pharmacokinetics of carbamazepine.","volume":"49","author":"Levy","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"R11-24-20210226","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00002826-199506000-00003","article-title":"The drug-drug interaction effects of haloperidol on plasma carbamazepine levels.","volume":"18","author":"Iwahashi","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"R12-24-20210226","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00007691-199408000-00006","article-title":"Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service.","volume":"16","author":"Jerling","year":"1994","journal-title":"Ther Drug Monit"},{"key":"R13-24-20210226","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0447.1994.tb01515.x","article-title":"Benzodiazepines in the treatment of catatonic syndrome.","volume":"89","author":"Ungvari","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"R14-24-20210226","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.comppsych.2013.06.003","article-title":"Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis.","volume":"54","author":"Lin","year":"2013","journal-title":"Compr Psychiatry"},{"key":"R15-24-20210226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/2319-4170.107162","article-title":"Rapid relief of catatonia in mood disorder by lorazepam and diazepam.","volume":"36","author":"Huang","year":"2013","journal-title":"Biomed J"},{"key":"R16-24-20210226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11920-010-0113-y","article-title":"Catatonia: diagnosis, classification, and treatment.","volume":"12","author":"Francis","year":"2010","journal-title":"Curr Psychiatry Rep"},{"key":"R17-24-20210226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/jnp.2009.21.4.371","article-title":"Catatonia: clinical aspects and neurobiological correlates.","volume":"21","author":"Daniels","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R18-24-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Treatment with lorazepam and electroconvulsive therapy.","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"R19-24-20210226","first-page":"576","article-title":"Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report.","volume":"33","author":"Tsai","year":"2010","journal-title":"Chang Gung Med J"},{"key":"R20-24-20210226","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-3223(98)00109-7","article-title":"Serum iron in catatonia and neuroleptic malignant syndrome.","volume":"44","author":"Lee","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R21-24-20210226","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","article-title":"Neuroleptic malignant syndrome. Review of response to therapy.","volume":"149","author":"Rosenberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"R22-24-20210226","first-page":"381","article-title":"Drug treatment of the neuroleptic malignant syndrome.","volume":"27","author":"Sakkas","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"R23-24-20210226","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1192\/bjp.158.5.706","article-title":"The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.","volume":"158","year":"1991","journal-title":"Br J Psychiatry"},{"key":"R24-24-20210226","first-page":"183","article-title":"Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia Clin N","volume":"25","author":"Gurrera","year":"2002","journal-title":"europharmacol"},{"key":"R25-24-20210226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome.","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"key":"R26-24-20210226","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1176\/ajp.146.6.717","article-title":"A prospective analysis of 24 episodes of neuroleptic malignant syndrome.","volume":"146","author":"Rosebush","year":"1989","journal-title":"Am J Psychiatry"},{"key":"R27-24-20210226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00004583-199902000-00018","article-title":"Neuroleptic malignant syndrome in children and adolescents.","volume":"38","author":"Silva","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R28-24-20210226","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004714-200004000-00021","article-title":"Residual catatonic state following neuroleptic malignant syndrome.","volume":"20","author":"Caroff","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R29-24-20210226","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00124509-199906000-00008","article-title":"Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.","volume":"15","author":"Nisijima","year":"1999","journal-title":"J ECT"},{"key":"R30-24-20210226","first-page":"25","article-title":"Neuroleptic malignant syndrome.","volume":"24","author":"Caroff","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"R31-24-20210226","first-page":"208","article-title":"Neuroleptic malignant syndrome: long-term follow-up of 20 cases.","volume":"52","author":"Pope","year":"1991","journal-title":"J Clin Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:51:46Z","timestamp":1620960706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201510270-00024"}},"subtitle":["Short Communication and Literature Review"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":31,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001752","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}